Investigational Site Number :3800004

Milan 20162

1 studies enrolling now · 7 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Breast Cancer, Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP), Immune Thrombocytopenia, Non-relapsing Secondary Progressive Multiple Sclerosis, Non-small Cell Lung Cancer, Parkinson's Disease, Pleural Mesothelioma

Studies at this site

• Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment — Recruiting now
• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) — Stopped early
• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early
• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed
• Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation — Stopped early
• A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps — Completed